Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
4
×
biotech
boston blog main
boston top stories
cancer drugs
4
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
medical device
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biontech
eli lilly
fda
glaxosmithkline
ipo
novartis
What
roundup
bio
cancer
drug
according
acquisitions
akcea
appetite
biggest
biotech
black
bread
build
butter
buy
buyout
cases
cash
centers
ceo
cigarettes
company’s
control
daniel
deaths
debut
despite
diabetes
diamond’s
disease
drugs
dyne’s
electronic
eli
family
giant
gilead
grabbed
hardest
hasn’t
Language
unset
Current search:
amgen
×
" cancer drugs "
×
@xconomy.com
4 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More